98 results
Page 3 of 5
8-K
EX-10.1
vxscxzqy5 cdt
13 Jun 19
Departure of Directors or Certain Officers
4:58pm
8-K
EX-10.1
hrp39 3n8
29 Nov 18
Entry into a Material Definitive Agreement
8:14pm
425
EX-10.1
cntg5l7nng
29 Nov 18
Business combination disclosure
8:12pm
S-4/A
EX-10.45
erxb2 dqpxa
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-99.1
euxbcgs70tcrzy 84b
1 Nov 18
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing
5:01pm
8-K
EX-10.1
mvnmzkstc340ccsf
1 Nov 18
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing
5:01pm
425
EX-99.1
urdqn5cdxtn2065sn
1 Nov 18
Business combination disclosure
5:00pm
425
EX-10.1
aqstz
1 Nov 18
Business combination disclosure
5:00pm
8-K
EX-2.1
8gfsrovmj6sj94l
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.1
l1eqvzgh6 kh
9 Aug 18
Business combination disclosure
5:17pm